Presentation Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens Presenter: Harvey White October 31, 2013 REGISTER for free or LOG IN to view this content ACS/AMI Presentation TCT 2013 Up Next Presentation Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI Presenter: Fausto Feres October 31, 2013 More slides + Presentation Risk Stratified Antiplatelet Therapy in ACS and During PCI: State-of-the-Art Presenter: Harvey White October 31, 2013 Presentation A Surgeon Is the Best Person to Determine Risk Assessment for TAVR! Presenter: A. Pieter Kappetein October 31, 2013 We Recommend
Presentation Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI Presenter: Fausto Feres October 31, 2013
Presentation Risk Stratified Antiplatelet Therapy in ACS and During PCI: State-of-the-Art Presenter: Harvey White October 31, 2013
Presentation A Surgeon Is the Best Person to Determine Risk Assessment for TAVR! Presenter: A. Pieter Kappetein October 31, 2013